Advertising
Supported by
Cases in Florida and Texas exceed 600,000, California. Life in China, where the pandemic began, is returning to normal.
Right now
Italy reported 1,210 new cases, at the time the number exceeded 1,000 and the highest number in the country since May 4.
The Food and Drug Administration (FDA) on Sunday legalized the emergency use of blood plasma from others who have recovered from coronavirus infections for the remedy of patients hospitalized with Covid-19. Food and Drug Administration commissioner Dr. Stephen M. Hahn said in a call to reporters that the company was “encouraged by the first promising knowledge we saw.”
He said data from this year’s studies showed that the remedy was safe and had a prospect of being useful. However, he added that the firm would continue to work with researchers reading the remedy and would update the authorization if necessary.
The resolution was mainly based on an initial data investigation. He did not come with a randomized group, regarded as the most powerful form of evidence, and Dr. Hahn encouraged the continuation of those trials. Prior authorization for the use of hydroxychloroquine was revoked on the basis of the effects of the upcoming studies.
Dr. Peter Marks, director of the F.D.A. Center for Biological Products, Evaluation and Research, said in the call that more than 70,000 patients had already gained convalescent plasma as a component of the agency’s expanded access program. The resolution to authorize the remedy for more doctors to use it was based on evidence suggesting that, when administered at the beginning of the disease, plasma “may improve outcomes and decrease mortality.”
“We are that convalescent plasma can be used safely in this context,” he said.
The authorization includes recommendations for physicians where patients deserve to be considered. Those who were treated “within 3 days of diagnosis, with plasma containing the highest levels of antibodies, compared to lower levels of antibodies, gave the impression of gaining more advantages from this remedy than others,” Dr. Marks said. “And those who seemed to get the maximum advantages were those under the age of 80 who had no fan.”
The F.D.A. The announcement was expected to come sooner, but an intervention through high-level scientists caused a delay that seemed to have angered President Trump. In the appeal, Dr. Hahn stated that the resolution authorizing redress was taken “only on the basis of science and knowledge and not on anything else.”
Trump management officials met with Congressional leaders last month and told them they were likely to give an emergency approval to a coronavirus vaccine before phase 3 clinical trials in the United States ended, in all likelihood as early as last September, according to two others. people reported on the discussion.
This resolution would be highly likely and would probably raise considerations as to whether the administration is cutting approvals for political purposes.
The two-hour assembly with Treasury Secretary Steven Mnuchin; White House chief of staff Mark Meadows; House Speaker Nancy Pelosi; and Senator Chuck Schumer, the Democratic leader, held the night of July 30 at the Pelosi convention hall.
During the discussion, those briefed on this topic stated that Meadows indicated that a vaccine evolved through AstraZeneca and Oxford University as the most likely candidate.
The projected schedule shows the hopes of managing a primary victory over the pandemic before the election. It also suggests that officials expect a lot from the effects of drug trials abroad, which began before national trials.
Senior management officials questioned the narrative, saying that Mr. Meadows and Mr. Mnuchin were misrepresented or misinterpreted on each and every major issue.
The AstraZeneca-Oxford team is recently conducting Phase 2 and Phase 3 trials in the UK, Brazil and South Africa. Investigators said they expected effects until September at the earliest. Along with other pharmaceutical companies, AstraZeneca has also begun large-scale trials in the United States, starting recruiting volunteers just a few days ago.
The Food and Drug Administration requests clinical trials with U.S. patients. Before approving vaccines for use in this country.
Comments from management officials at the assembly recommend that the White House be more positive about customers of an immediate vaccine that opposes a virus that has killed 176,000 Americans than their own clinical experts.
In a briefing with reporters on August 13, Francis Collins, director of the National Institutes of Health, said it would be “surprising” if the vaccine progression progressed quickly enough for the Food and Drug Administration to approve one until the end of next month. Array “Maybe November, December would be my bet,” he says.
Dr. Anthony S. Fauci, the infectious disease expert in the coronavirus runners group, said that early next year is the maximum possible time.
Trump’s political fate has plummeted to voters’ deep discontent at how he and his administration have treated the pandemic, which his Democratic opponent, former Vice-President Joseph R. Biden Jr., has put in the spotlight of his campaign.
A White House spokeswoman did not respond to a request for comment.
A senior management official who reported on the assembly said that neither Meadows nor Mnuchin had reported that a vaccine could be approved by the end of September. The official insisted that management would not approve a vaccine solely on the basis of clinical trials abroad.
A spokesman for Meadows denied that he had the prospects of AstraZeneca. Neither Mnuchin, according to Treasury Department spokeswoman.
President Vladimir V. Putin and officials announced this month that a billion doses of a Russian coronavirus vaccine would soon be deployed.
But if they now imagined themselves bowing to save the world, Russian fitness would be more defensive.
“Some foreign colleagues, who must have felt some festivals and competitive benefits of Russian product, tried to make explicit comments that we consider absolutely unfounded,” Health Minister Mikhail Murashko said at a press convention in Moscow.
Skeptics pointed out that the vaccine, which the Russians call Sputnik V, has not been tested in the type of giant randomized controlled trials that aim to identify protection and efficacy. By skipping such tests, Russia can put other people in danger to earn propaganda points, fitness experts warn.
“If we’re looking to take the threat of hurting a lot of other people or give them something that doesn’t work, we might just start doing it, you know, next week if we want to,” said Dr. Anthony S Fauci, director of the National Institute of Allergy and Infectious Diseases.
Aleksandr Gintsburg, director of the Gamaleya Institute, the clinical framework that designed the vaccine, said that refusal is simply “a struggle for market share.”
The wonderful powers of the world are suffering to produce vaccines that, if successful and accepted by their own citizens and other countries, will only bring prestige but also geopolitical and economic benefits to the winner. The United States has invested billions of dollars in an effort called Operation Warp Speed.
Florida and Texas sunday the time and third state to exceed 600,000 reported cases since the start of the pandemic, according to a New York Times database. Both states joined California, which crossed that threshold on August 14.
Texas, with more than 5,000 cases reported in the following week, reached 600,099 cases on Sunday.
Texas and Florida, the time and the third most populous state in California, experienced an increase in infections this summer after state officials eased the blocking measures.
However, new instances in the 3 states have declined in recent weeks, and Florida recorded a 40% drop in its seven-day average from the two-week-old average. The decline in Texas less dramatic, with a decline of 22% during the same period. The minimum in the number of instances in California 7%.
However, reported deaths remain the main ones in the 3 states. Florida recorded 106 new deaths Saturday, for a total of 10,324 since the start of the pandemic. Texas recorded 167 deaths, for a total of 11650, and California counted at least 153 new deaths on August 22, for a total of 12,141.
Advertising